Characteristics of Synchronous Cancers in Gastric Cancer Patients

Ja Seong Bae; Jun Ho Lee; Keun Won Ryu; Young Woo Kim; Jae Moon Bae

doi:10.4143/crt.2006.38.1.25

Articles

Page Path: HOME > Cancer Res Treat > Volume 38(1); 2006 > Article

Original Article Characteristics of Synchronous Cancers in Gastric Cancer Patients: Ja Seong Bae, M.D., Jun Ho Lee, M.D., Keun Won Ryu, M.D., Young Woo Kim, M.D., Jae Moon Bae, M.D.; Cancer Research and Treatment : Official Journal of Korean Cancer Association 2006;38(1):25-29.
DOI: https://doi.org/10.4143/crt.2006.38.1.25
Published online: February 28, 2006

Center for Gastric Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.

Correspondence: Jae Moon Bae, Research Institute & Hospital, National Cancer Center, 809 Madu1-dong, Ilsan-gu, Goyang 411-769, Korea. (Tel) 82-31-920-1625, (Fax) 82-31-920-1520, jmoonbae@ncc.re.kr

• Received: December 14, 2005 • Accepted: January 16, 2006

10,139 Views
58 Download
19 Crossref

prev next

Full Article

Download PDF

Abstract

Purpose
The primary objective of the current study was to investigate the characteristics of synchronous cancers in gastric cancer patients.
Materials and Methods
We analyzed the 2,237 patients who were diagnosed between December 2000 and December 2003 with gastric cancer and synchronous cancers of organs other than the stomach.
Results
73 (3.3%) of a total of 2,237 gastric cancer patients had synchronous primary cancers. Among these 73 patients, 71 had one synchronous cancer, and two patients had double synchronous cancers. Colorectal cancer (26 patients, 34.7%) was the most frequently encountered synchronous cancer, followed by cancer of the lung (16 patients, 21.3%), esophagus (13 patients, 17.2%), and liver (8 patients, 10.7%). Synchronous cancers were detected with increased frequency in the elderly, in the patients with multiple gastric cancers, in the patients with differentiated gastric cancer, and in the patients with early gastric cancer, as determined on univariate analysis, but the differentiation of gastric cancers was the only risk factor for synchronous cancers on the multivariate analysis.
Conclusions
The differentiation of gastric cancer cells may be a risk factor for synchronous cancers in gastric cancer patients. Careful surveillance by the physician for synchronous cancer is warranted for the patients suffering from gastric cancer.
Key words: Synchronous cancer, Stomach neoplasms, Colorectal neoplasms

INTRODUCTION

Gastric cancer is the most frequently encountered cancer in Korea, and it represents the second most common cause of cancer death (1). The recent outcomes of gastrectomy for patients with stomach cancer have significantly improved as the result of the advances in early detection techniques, the surgical procedures and the perioperative management protocols (2,3). As the number of long-term survivors after gastrectomy increases, a concomitant increase in the incidence of second malignancies after gastrectomy has been noted (4,5).

Second malignancies are clinically relevant with regard to their diagnosis and/or treatment (6,7). Recent advances in early detection and surgical techniques have made it possible to cure the patients who exhibit second malignancies with using minimally invasive techniques. Insufficient vigilance by the physician with regard to synchronous cancers makes it possible that a candidate for such minimally invasive treatments will be overlooked.

A number of studies have been conducted regarding the development of second malignancies in the patients suffering with primary gastric cancer. The results of previous studies conducted in several countries have revealed a variable incidence of multiple primary cancers (4~6,8,9). However, those reports have principally focused on metachronous cancers occurring after a diagnosis of gastric cancer (4~6,8).

In this current study, we have attempted to determine both the incidence rate and the relevant characteristics of synchronous cancers arising in gastric cancer patients.

MATERIALS AND METHODS

We conducted a retrospective review between December 2000 and December 2003 of the prospectively collected gastric cancer database at the Center for Gastric Cancer, The National Cancer Center (NCC) and we uncovered 2,237 registered patients who had been diagnosed with gastric adenocarcinoma.

Synchronous cancers were defined as the cancers detected in the patients suffering with gastric cancer, in their organs other than the stomach. Each cancer was verified as malignant via histological evaluation. These cancers were assumed to be synchronous in the cases in which the time interval between the appearances of the two tumors did not exceed 6 months. In the cases that both the stomach and synchronous cancer had a similar histology, further immunohistochemical staining was performed to discriminate the synchronous cancer from the metastatic cancer.

The clinicopathological characteristics, including age, gender, histopathological classification, the preoperative diagnosis of early or advanced gastric cancer and multiplicity, were compared between the synchronous cancer patients and those patients without synchronous cancers. According to the JGCA classifications, tubular carcinoma and papillary adenocarcinoma were both classified as differentiated type cancers, whereas poorly differentiated adenocarcinoma, mucinous adenocarcinoma and signet ring cell carcinoma were classified as undifferentiated-type cancers (10). The relevant characteristics of the synchronous cancers, including the operability and the time of diagnosis, were analyzed separately.

For statistical analysis, we employed the Student's t test and the chi-squared test (or Fisher's exact test when the numbers were small). Multiple regression analysis was performed with using a logistic model. A probability value of p<0.05 was considered to be statistically significant.

RESULTS

1) Clinicopathological characteristics of the patients

Among the 2,237 gastric cancer patients, we determined that 73 (3.3%) patients had manifested synchronous tumors in their organs other than the stomach. Among these 73 patients, two patients (2.7%) had triple cancers, and the other patients exhibited single synchronous cancers. There was no patient with familial cancers such as hereditary non-polyposis colorectal cancer (HNPCC).

On the univariate analysis, the mean age (±SD) was higher for the patients with synchronous cancers than for the patients without synchronous cancers (63.7±9.2 versus 59.5±12.5, respectively, p<0.001). The gender distribution revealed a significant difference between the two groups (p=0.049). The multiple gastric cancer patients exhibited synchronous cancers at a higher frequency than did the single gastric cancer patients (p=0.038), and the patients with differentiated-type cancers exhibited synchronous cancers at a higher frequency than did the patients with undifferentiated-type cancers (p<0.001). The proportion of early gastric cancer was higher for the patients with synchronous cancer than for the patients without synchronous cancers (p<0.001) (Table 1).

Multivariate analysis indicated that only the histologic type of stomach cancer was an independent risk factor for synchronous cancer in the patients with gastric cancer (RR=0.116, 95% CI: 0.056~0.242, p<0.001) (Table 4).

2) Distribution and number of the synchronous cancers

The synchronous cancers detected in the gastric cancer patients were most frequently located in the colon and rectum, and this was followed by the lung, esophagus and liver (Fig. 1). Synchronous cancers in these four major sites accounted for 84.0% of all the detected synchronous cancers.

Two of the 73 patients had developed two (double) synchronous cancers. One of these patients had esophageal and prostate cancer. The other patient had lung and colorectal cancer.

3) Operations for gastric and synchronous cancers

Gastric cancer operations were conducted in only 46 (63%) of the 73 gastric cancer patients. The operability of gastric cancer varied according to the types of synchronous cancer exhibited. The operability was highest in the cases of synchronous colorectal cancer (80.8%); it was 53.8% in the cases of esophageal cancer, and 50% in the cases of lung cancer (Table 2).

4) Time interval between gastric cancer and synchronous cancers

Among 73 cases, 31 (41.3%) were simultaneously diagnosed with gastric cancer and synchronous cancer. 31 patients (41.3%) were diagnosed with synchronous cancer prior to the diagnosis of gastric cancer, and 13 cases (17.4%) were diagnosed with synchronous cancer after the diagnosis of gastric cancer. More than half of the patients with lung, esophagus and liver cancers were simultaneously diagnosed with gastric cancer. 19 (73.0%) out of the 26 gastric and synchronous colorectal cancer patients were diagnosed prior to being diagnosed with gastric cancer. 3 patients (11.5%) were simultaneously diagnosed with gastric cancer, and 4 patients (15.5%) were diagnosed after the diagnosis of gastric cancer (Fig. 2).

5) Relationship of the stages between gastric cancer and synchronous cancers

Of the 26 gastric and synchronous colorectal cancer patients, 20 patients were operated on. Of the 16 gastric and synchronous lung cancer patients, 8 patients were operated on. Of the 13 gastric and synchronous esophagus cancer patients, 7 patients were operated on. Patients with early gastric lesions were more frequently diagnosed with synchronous colorectal or esophageal cancers than were the patients with advanced gastric lesions. With regard to lung cancer, the combination of advanced gastric cancer and early-stage lung cancer was more frequently encountered than the combination of early gastric cancer and advanced lung cancer (Table 3).

DISCUSSION

As the long term survival for each cancer increases and screening programs are better applied to detect the early cancer lesions, more synchronous cancers will be discovered.

In the current study, the incidence of synchronous cancers in gastric cancer patients was determined to be 3.3%. This incidence of synchronous cancers in the gastric cancer patients was higher than that reported in previous studies (7,8). This discrepancy might be attributed to the fact that our study included all the patients who underwent surgery, as well as those who had only been diagnosed. The previous studies included only the patients who had undergone surgery. The other reason for the difference might lie in the fact that all of the patients with synchronous colorectal cancer in our study had undergone routine preoperative gastroscopy at the NCC.

Colorectal cancer was the most frequently discovered synchronous cancer in the gastric cancer patients; this was followed by cancers of the lung, esophagus and liver in decreasing order, which was similar to the findings of other reports (6,7,11). The majority of colorectal cancers were discovered prior to a diagnosis of gastric cancer. The majority of the gastric cancer patients with synchronous colorectal cancer were in the early stages of gastric cancer. This result may be associated with the recent trend towards a rapid increase in the incidence of colorectal cancer in Korea (1), and it may also be partially attributed to the routine preoperative gastroscopy that is administered to all colorectal cancer patients at our institution. Therefore, the gastric cancer patients with synchronous colorectal cancer tended to be in the early stages of gastric cancer. However, we were unable to confirm any correlative factors between gastric and colorectal cancer. Therefore, further investigation will be necessary in order to explain the apparent association between these two cancers.

The incidence of synchronous cancers was significantly higher in men than in women, and it also generally increased with age. These findings were consistent with the previous reports conducted in other countries (6,11,12). As the incidence of cancer increases with age, it appears likely that the actual incidence of synchronous cancer in elderly gastric cancer patients may be somewhat higher than expected. A high incidence of differentiated gastric cancer was found in this study, and this appears to be associated with the high incidence of early-stage gastric cancer (13,14).

27 patients (37%) in this study had not undergone therapeutic surgery. 24 of them were diagnosed with resectable gastric cancer, and the remaining 3 had unresectable gastric cancer. Advanced synchronous cancers were one of the most important factors when deciding the most appropriate treatment modality for the patients. It was presumed that the primary factor influencing the treatment for the second primary cancer was the stage of the second primary cancer, rather than the treatment administered for the primary gastric cancer.

Kaibara et al. also showed that the incidence of synchronous cancer with multiple gastric cancers was statistically higher than that of synchronous cancer with single gastric cancer, which was consistent with our results (15). It is presumed that synchronous cancer and multiple gastric cancer are associated with such genetic factors as microsatellite instability (16,17). Our results supported the implication that the development of synchronous cancer may be associated with certain genetic factors (9).

CONCLUSIONS

Our results suggested that synchronous cancers in gastric cancer patients could have an influence on deciding upon an appropriate treatment modality. Our results also emphasized the clinical importance for physicians to stay alert and search for synchronous cancers in the patients suffering from gastric cancer.

REFERENCES

1. Shin HR, Jung KW, Won YJ, Park JG. 2002 Annual report of the Korea Central Cancer Registry: Based on registered data from 139 Hospitals. Cancer Res Treat. 2004;36:103–114. Article PubMed PMC PDF
2. Akoh JA, Macintyre IM. Improving survival in gastric cancer. Review of 5-year survival rates in English language publications from 1970. Br J Surg. 1992;79:193–199. PMID: 1555082Article PubMed
3. Maehara Y, Kakeji Y, Oda S, Takahashi I, Akazawa K, Sugimachi K. Time trends of surgical treatment and the prognosis for Japanese patients with gastric cancer. Br J Cancer. 2000;83:986–991. PMID: 10993643Article PubMed PMC
4. Lundegardh G, Hansson LE, Nyren O, Adami HO, Krusemo UB. The risk of gastrointestinal and other primary malignant disease following gastric cancer. Acta Oncol. 1991;30:1–6. PMID: 2009177Article
5. Hiyama T, Hanai A, Fujimoto I. Second primary cancer after diagnosis of stomach cancer in Osaka, Japan. Jpn J Cancer Res. 1991;82:762–770. PMID: 1908843Article PubMed PMC
6. Ikeda Y, Saku M, Kawanaka H, Nonaka M, Yoshida K. Features of second primary cancer in patients with gastric cancer. Oncology. 2003;65:113–117. PMID: 12931016Article PubMed
7. Yoshino K, Asanuma F, Hanatani Y, Otani Y, Kumai K, Ishibiki K. Multiple primary cancers in the stomach and another organ: frequency and the effects on prognosis. Jpn J Clin Oncol. 1985;15(suppl 1):183–190. PMID: 4009981PubMed
8. Dinis-Ribeiro M, Lomba-Viana H, Silva R, Moreira-Dias L, Lomba-Viana R. Associated primary tumors in patients with gastric cancer. J Clin Gastroenterol. 2002;34:533–535. PMID: 11960064Article PubMed
9. Kato I, Kito T, NAkazato H, Tominaga S. Second malignancy in stomach cancer patients and its possible risk factors. Jpn J Clin Oncol. 1986;16:373–381. PMID: 3795533PubMed
10. Japanese Classification of Gastric Carcinoma - 2nd English edition. Gastric Cancer. 1998;1:10–24. PMID: 11957040Article PubMed PDF
11. Ikeguchi M, Ohfuji S, Oka A, Tsujitani S, Maeda M, Kaibara N. Synchronous and metachronous primary malignancies in organs other than the stomach in patients with early gastric cancer. Hepatogastroenterology. 1995;42:672–676. PMID: 8751233PubMed
12. Ikeda Y, Saku M, Kishihara F, Maehara Y. Effective follow-up for recurrence or a second primary cancer in patients with early gastric cancer. Br J Surg. 2005;92:235–239. PMID: 15609385Article PubMed
13. Adachi Y, Yasuda K, Inomata M, Sato K, Shiraishi N, Kitano S. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated. Cancer. 2000;89:1418–1424. PMID: 11013353Article PubMed
14. Arai T, Esaki Y, Inoshita N, Sawabe M, Kasahara I, Kuroiwa K, et al. Pathologic characteristics of gastric cancer in the elderly: a retrospective study of 994 surgical patients. Gastric cancer. 2004;7:154–159. PMID: 15449203Article PubMed
15. Kaibara N, Maeta M, Ikeguchi M. Patients with multiple primary gastric cancers tend to develop second primaries in organs other than the stomach. Surg Today. 1993;23:186–188. PMID: 8467167Article PubMed
16. Yokozaki H, Semba S, Fujimoto JY, Tahara E. Microsatellite instabilities in gastric cancer patients with multiple primary cancers. Int J Oncol. 1999;14:151–155. PMID: 9863022Article PubMed
17. Miyoshi E, Haruma K, Hiyama T, Tanaka S, Yshihara M, Shimamoto F, et al. Microsatellite instability is a genetic marker for the development of multiple gastric cancers. Int J Cancer. 2001;95:350–353. PMID: 11668515Article PubMed

Fig. 1

Location and number of synchronous cancers.

Fig. 2

Distribution of synchronous cancers according to the time of diagnosis of gastric cancer. ^*gastric cancer.

Table 1

Clinicopathologic features of gastric cancer patients with or without synchronous cancers

Table 2

Causes of non-operation for the patients with gastric and synchronous cancers

Table 3

Comparison of the stage between gastric and synchronous cancers

^*early gastric cancer, ^†advanced gastric cancer, ^‡stage I or II, ^§stage III or IV.

Table 4

Logistic regression multivariate analysis for the variables associated with synchronous cancers in the patients with gastric cancer

^*standard error, ^†relative risk, ^‡confidence interval.

Figure & Data

REFERENCES

Citations

Citations to this article as recorded by

Synchronous Triple Malignancy of Esophagus, Pancreas, and Pyriform Sinus: A Prima Facie Report
Sekhar Saha, Varun Goel, Arnab Chakraborty, Vineet Talwar
Indian Journal of Surgical Oncology.2024; 15(S2): 349. CrossRef
Synchronous Gastric and Colonic Adenocarcinoma: A Case Report With its Molecular Implications
Lakshmipriya V, Sarah Grace Priyadarshini , Neha Agarwal, Padmapriya B S
Cureus.2024;[Epub] CrossRef
Triple metachronous primary cancer of uterus, colon, and breast cancer
Guanqiao Li, Jia Yao, Tangna Wu, Yaxiong Chen, Zhenping Wang, Yiming Wang, Fen Wang, Rui Zhong, Shiping Yang
Medicine.2020; 99(34): e21764. CrossRef
Gastric cancer and intrahepatic cholangiocarcinoma
Alex Emmanuel Elobu, Ashok Thorat, Vianney Kweyamba, Rakesh Rai
Formosan Journal of Surgery.2019; 52(3): 107. CrossRef
Clinicopathologic characteristics and survival rate in patients with synchronous or metachronous double primary colorectal and gastric cancer
Ji-Hyeon Park, Jeong-Heum Baek, Jun-Young Yang, Won-Suk Lee, Woon-Kee Lee
Korean Journal of Clinical Oncology.2018; 14(2): 83. CrossRef
Can positron emission tomography detect colorectal adenomas and cancers?
Kimihiro Igarashi, Kinichi Hotta, Kenichiro Imai, Yuichiro Yamaguchi, Sayo Ito, Noboru Kawata, Masaki Tanaka, Naomi Kakushima, Kohei Takizawa, Hiroyuki Matsubayashi, Masahiro Endo, Kouiku Asakura, Takuma Oishi, Tadakazu Shimoda, Hiroyuki Ono
Journal of Gastroenterology and Hepatology.2017; 32(3): 602. CrossRef
Triple synchronous primary malignancies: a rare occurrence
Heather Katz, Hassaan Jafri, Linda Brown, Toni Pacioles
BMJ Case Reports.2017; 2017: bcr-2017-219237. CrossRef
A Concurrence of Adenocarcinoma with Micropapillary Features and Composite Glandular-Endocrine Cell Carcinoma in the Stomach
Ji-Hoon Kim, Dae-Woon Eom, Cheon-Soo Park, Jae-Young Kwak, Eun-Hwa Park, Jin-Ho Kwak, Hyuk-Jae Jang, Kun-Moo Choi, Myung-Sik Han
Journal of Gastric Cancer.2016; 16(4): 266. CrossRef
Synchronous triple primary cancers occurring in the stomach, kidney, and thyroid
Sung Jin Oh, Dong Sik Bae, Byoung Jo Suh
Annals of Surgical Treatment and Research.2015; 88(6): 345. CrossRef
Risk factors for double primary malignancies and their clinical implications in patients with sporadic gastric cancer
I. Cho, J.Y. An, I.G. Kwon, Y.Y. Choi, J.H. Cheong, W.J. Hyung, S.H. Noh
European Journal of Surgical Oncology (EJSO).2014; 40(3): 338. CrossRef
Concurrent Robot-Assisted Distal Gastrectomy and Partial Nephrectomy for Synchronous Early Gastric Cancer and Renal Cell Carcinoma: An Initial Experience
Jieun Kim, Su Mi Kim, Jeong Eun Seo, Min Gew Choi, Jun Ho Lee, Tae Sung Sohn, Sung Kim, Jae Moon Bae, Seong Il Seo
Journal of Gastric Cancer.2014; 14(3): 211. CrossRef
Concurrent Robot-Assisted Distal Gastrectomy and Partial Nephrectomy for Synchronous Early Gastric Cancer and Renal Cell Carcinoma: An Initial Experience
Jieun Kim, Su Mi Kim, Jeong Eun Seo, Min Gew Choi, Jun Ho Lee, Tae Sung Sohn, Sung Kim, Jae Moon Bae, Seong Il Seo
Journal of Gastric Cancer.2014; 14(3): 211. CrossRef
Management of gastric epithelial neoplasia in patients requiring esophagectomy for esophageal cancer
H. I., G. H. Kim, D. Y. Park, Y. D. Kim, B. E. Lee, D. Y. Ryu, D. U. Kim, G. A. Song
Diseases of the Esophagus.2013; 26(6): 603. CrossRef
Synchronous lung and gastric cancers successfully treated with carboplatin and pemetrexed: a case report
Takashi Sato, Koji Tomaru, Tomoko Koide, Makoto Masuda, Masaki Yamamoto, Naoki Miyazawa, Yoshiaki Inayama, Takeshi Kaneko, Yoshiaki Ishigatsubo
Journal of Medical Case Reports.2012;[Epub] CrossRef
Synchronous primary gastric cancer and renal cell carcinoma: A case report and literatures review
Kung-Ning Hu, Wei-Hong Lai, Po-Tsang Tseng, Wen-Ching Wang, Kun-Hung Shen
Urological Science.2012; 23(1): 28. CrossRef
Synchronous multifocal early gastric cancers and rectal adenocarcinoma: Lesson learnt from image‐enhanced endoscopy
Boon Eu Andrew KWEK, Tiing Leong ANG, Kwong Ming FOCK, Eng Kiong TEO
Journal of Digestive Diseases.2011; 12(3): 226. CrossRef
Clinical improvement of membranous nephropathy after endoscopic resection of double early gastrointestinal cancers
Satoshi Matsui, Hiroko Tsuji, Yukinobu Takimoto, Shinji Ono
Clinical and Experimental Nephrology.2011; 15(2): 285. CrossRef
Microsatellite Instability Is Associated with the Clinicopathologic Features of Gastric Cancer in Sporadic Gastric Cancer Patients
Shin Hyuk Kim, Byung Kyu Ahn, Young Su Nam, Joo Youn Pyo, Young Ha Oh, Kang Hong Lee
Journal of Gastric Cancer.2010; 10(4): 149. CrossRef
Second primary cancers in patients with gastric cancer
Oktay Buyukasik, Ahmet Hasdemir, Yusuf Gulnerman, Cavit Col, Ozgur Ikiz
Radiology and Oncology.2010;[Epub] CrossRef

PubReader
ePub Link

Cite

CITE: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Characteristics of Synchronous Cancers in Gastric Cancer Patients

Cancer Res Treat. 2006;38(1):25-29. Published online February 28, 2006

DOI: https://doi.org/10.4143/crt.2006.38.1.25

XML Download

Abstract
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
CONCLUSIONS
REFERENCES

Characteristics of Synchronous Cancers in Gastric Cancer Patients

Fig. 1 Location and number of synchronous cancers.

Fig. 2 Distribution of synchronous cancers according to the time of diagnosis of gastric cancer. *gastric cancer.

Fig. 1

Fig. 2

Characteristics of Synchronous Cancers in Gastric Cancer Patients

Table 1

Clinicopathologic features of gastric cancer patients with or without synchronous cancers

Table 2

Causes of non-operation for the patients with gastric and synchronous cancers

Table 3

Comparison of the stage between gastric and synchronous cancers

^*early gastric cancer, ^†advanced gastric cancer, ^‡stage I or II, ^§stage III or IV.

Table 4

Logistic regression multivariate analysis for the variables associated with synchronous cancers in the patients with gastric cancer

^*standard error, ^†relative risk, ^‡confidence interval.

Table 1 Clinicopathologic features of gastric cancer patients with or without synchronous cancers

Table 2 Causes of non-operation for the patients with gastric and synchronous cancers

Table 3 Comparison of the stage between gastric and synchronous cancers

^*early gastric cancer, ^†advanced gastric cancer, ^‡stage I or II, ^§stage III or IV.

Table 4 Logistic regression multivariate analysis for the variables associated with synchronous cancers in the patients with gastric cancer